Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Heron Therapeutics (HRTX) Gross Profit (2016 - 2026)

Heron Therapeutics filings provide 11 years of Gross Profit readings, the most recent being $24.1 million for Q1 2026.

  • On a quarterly basis, Gross Profit fell 20.93% to $24.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $107.2 million, a 2.43% decrease, with the full-year FY2025 number at $113.6 million, up 7.5% from a year prior.
  • Gross Profit hit $24.1 million in Q1 2026 for Heron Therapeutics, down from $29.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $30.6 million in Q4 2024 to a low of $11.5 million in Q2 2022.
  • Median Gross Profit over the past 5 years was $24.1 million (2026), compared with a mean of $21.1 million.
  • Biggest five-year swings in Gross Profit: skyrocketed 155.34% in 2022 and later decreased 20.93% in 2026.
  • Heron Therapeutics' Gross Profit stood at $17.4 million in 2022, then skyrocketed by 39.92% to $24.3 million in 2023, then increased by 25.48% to $30.6 million in 2024, then dropped by 3.55% to $29.5 million in 2025, then fell by 18.31% to $24.1 million in 2026.
  • The last three reported values for Gross Profit were $24.1 million (Q1 2026), $29.5 million (Q4 2025), and $26.3 million (Q3 2025) per Business Quant data.